CN1186313C - Methof for preparing l-valine and d-valine by using chemical resolution process - Google Patents
Methof for preparing l-valine and d-valine by using chemical resolution process Download PDFInfo
- Publication number
- CN1186313C CN1186313C CNB031321372A CN03132137A CN1186313C CN 1186313 C CN1186313 C CN 1186313C CN B031321372 A CNB031321372 A CN B031321372A CN 03132137 A CN03132137 A CN 03132137A CN 1186313 C CN1186313 C CN 1186313C
- Authority
- CN
- China
- Prior art keywords
- valine
- val
- acid
- preparing
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 23
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 title claims abstract description 19
- 239000000126 substance Substances 0.000 title claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 229960004295 valine Drugs 0.000 claims abstract description 20
- 229930182831 D-valine Natural products 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003513 alkali Substances 0.000 claims abstract description 11
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000004474 valine Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000012452 mother liquor Substances 0.000 claims abstract description 7
- YONLFQNRGZXBBF-KBPBESRZSA-N (2s,3s)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@H](C(=O)O)[C@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-KBPBESRZSA-N 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 17
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 238000006386 neutralization reaction Methods 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 239000001099 ammonium carbonate Substances 0.000 claims description 3
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 claims description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 2
- YONLFQNRGZXBBF-ZIAGYGMSSA-N (2r,3r)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@@H](C(=O)O)[C@@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-ZIAGYGMSSA-N 0.000 abstract description 11
- 238000003756 stirring Methods 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract description 6
- 150000002894 organic compounds Chemical class 0.000 abstract description 2
- 230000003287 optical effect Effects 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- -1 diaryl boron amino acid Chemical class 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- JETBVOLWZWPMKR-PGMHMLKASA-N (2r)-2-amino-3-methylbutanoic acid;hydrochloride Chemical compound Cl.CC(C)[C@@H](N)C(O)=O JETBVOLWZWPMKR-PGMHMLKASA-N 0.000 description 2
- NGEWQZIDQIYUNV-UHFFFAOYSA-N 2-hydroxy-3-methylbutyric acid Chemical compound CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 2
- PBNUQCWZHRMSMS-UHFFFAOYSA-N 5-propan-2-ylimidazolidine-2,4-dione Chemical compound CC(C)C1NC(=O)NC1=O PBNUQCWZHRMSMS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JETBVOLWZWPMKR-UHFFFAOYSA-N (1-carboxy-2-methylpropyl)azanium;chloride Chemical compound Cl.CC(C)C(N)C(O)=O JETBVOLWZWPMKR-UHFFFAOYSA-N 0.000 description 1
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical class OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
- JIRHAGAOHOYLNO-UHFFFAOYSA-N (3-cyclopentyloxy-4-methoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC1CCCC1 JIRHAGAOHOYLNO-UHFFFAOYSA-N 0.000 description 1
- ILYVXUGGBVATGA-UHFFFAOYSA-N 1-carboxyethylazanium;chloride Chemical compound Cl.CC(N)C(O)=O ILYVXUGGBVATGA-UHFFFAOYSA-N 0.000 description 1
- OSUIUMQSEFFIKM-UHFFFAOYSA-N 2-amino-4-methylsulfanylbutanoic acid;hydrochloride Chemical compound Cl.CSCCC(N)C(O)=O OSUIUMQSEFFIKM-UHFFFAOYSA-N 0.000 description 1
- MVODTGURFNTEKX-UHFFFAOYSA-N 2-bromo-n-(2-bromoethyl)-n-(thiophen-2-ylmethyl)ethanamine;hydrobromide Chemical compound Br.BrCCN(CCBr)CC1=CC=CS1 MVODTGURFNTEKX-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 150000008573 D-valines Chemical class 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- NGPGDYLVALNKEG-UHFFFAOYSA-N azanium;azane;2,3,4-trihydroxy-4-oxobutanoate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)C(O)C([O-])=O NGPGDYLVALNKEG-UHFFFAOYSA-N 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000012069 chiral reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
化学拆分法制备左旋缬氨酸和右旋缬氨酸的方法是一种手性有机化合物的制备技术,该方法以外消旋缬氨酸(DL-Val)为原料,以无机酸为溶剂,以右旋二苯甲酰酒石酸(D-DBTA)和左旋二苯甲酰酒石酸(L-DBTA)为拆分剂,将外消旋-缬氨酸与拆分剂按1∶0.5-1.2的比例溶于稀的无机酸溶液中,在60-100℃下搅拌0.5-2.0小时,再逐渐冷却至室温,滤出结晶盐,结晶盐和母液分别在水、酒精等溶剂中用碱中和,即分别得到左旋缬氨酸(D-Val)和右旋缬氨酸(L-Val),工艺路线为:见右式。
The method for preparing L-valine and D-valine by chemical resolution is a preparation technology of chiral organic compounds. The method uses racemic valine (DL-Val) as a raw material and an inorganic acid as a solvent. Use D-dibenzoyl tartaric acid (D-DBTA) and L-dibenzoyl tartaric acid (L-DBTA) as the resolving agent, and the ratio of racemic-valine to resolving agent is 1:0.5-1.2 Dissolve in dilute inorganic acid solution, stir at 60-100°C for 0.5-2.0 hours, then gradually cool to room temperature, filter out the crystalline salt, and neutralize the crystalline salt and mother liquor with alkali in water, alcohol and other solvents, namely To obtain left-handed valine (D-Val) and right-handed valine (L-Val) respectively, the process route is: see the right formula.
Description
一、技术领域1. Technical field
本发明是一种手性有机化合物的制备技术,尤其是一种左旋缬氨酸和右旋缬氨酸的制备方法。The invention relates to a preparation technology of chiral organic compounds, in particular to a preparation method of L-valine and D-valine.
二、背景技术2. Background technology
右旋缬氨酸(L-Val)是营养必须氨基酸,广泛用作食品和饲料添加剂,也用于临床氨基酸输液。左旋缬氨酸(D-Val)是重要的手性中间体,在医药和农药合成中应用广泛。如可用于合成抗肿瘤药物二芳基硼氨基酸酐和二芳基硼氨基乙酯类化合物;也可用于合成新型高效农药拟除虫菊酯和氯氟戊菊酯;其二碘代苯二甲酰衍生物具有抗菌活性;D-缬氨酸的青霉胺类衍生物具有增强免疫力抵抗AIDS等疾病的作用;它的α-酰基胞壁二肽衍生物具有增强生物体抵抗病原体的作用而本身没有毒性。D-valine (L-Val) is an essential amino acid for nutrition, widely used as a food and feed additive, and also used in clinical amino acid infusion. L-Valine (D-Val) is an important chiral intermediate widely used in the synthesis of medicine and pesticide. For example, it can be used to synthesize antitumor drugs diaryl boron amino acid anhydride and diaryl boron aminoethyl ester compounds; it can also be used to synthesize new high-efficiency pesticides pyrethroids and halvalerate; its diiodophthaloyl derivatives The substance has antibacterial activity; the penicillamine derivatives of D-valine have the effect of enhancing immunity against AIDS and other diseases; its α-acyl cell wall dipeptide derivatives have the effect of enhancing the organism's resistance to pathogens without itself toxicity.
关于D-Val的制备,文献报道的方法主要有诱导结晶法、微生物不对称转换法和化学拆分法。Regarding the preparation of D-Val, the methods reported in the literature mainly include induced crystallization, microbial asymmetric conversion and chemical resolution.
1965年Susenm Tatsumi等报道,在饱和或超饱和的外消旋缬氨酸(DL-Val)盐酸盐溶液中加入晶种,可以优先结晶出D-缬氨酸盐酸盐,中和D-缬氨酸盐酸盐后得D-缬氨酸,光学纯度为93%,收率低于10%。1988年Nohira Hiroyuki等在DL-蛋氨酸盐酸盐,DL-丙氨酸盐酸盐和磺酸存在下,通过诱导结晶,让D-缬氨酸盐酸盐优先从溶液中析出;他还在对二甲苯磺酸存在下进行诱导结晶,得到D-缬氨酸,其光学纯度为89.8%。诱导结晶法制取D-缬氨酸周期长、收率低、光学纯度也不高,不适合工业生产。In 1965, Susenm Tatsumi et al. reported that adding seed crystals to saturated or supersaturated racemic valine (DL-Val) hydrochloride solution could preferentially crystallize D-valine hydrochloride and neutralize D-Val. D-valine is obtained after valine hydrochloride, the optical purity is 93%, and the yield is less than 10%. In 1988, Nohira Hiroyuki et al. induced crystallization in the presence of DL-methionine hydrochloride, DL-alanine hydrochloride and sulfonic acid, allowing D-valine hydrochloride to preferentially precipitate from the solution; he is still working on Induced crystallization was carried out in the presence of xylenesulfonic acid to obtain D-valine with an optical purity of 89.8%. The production of D-valine by induced crystallization has a long period, low yield and low optical purity, and is not suitable for industrial production.
微生物不对称转换法有大量报道,有代表性的是意大利科学家M.Battilotti和U.Barberini用放射形土壤杆菌所产生的酶催化水解DL-5-异丙基海因.该菌富含海因水解酶和氨甲酰水解酶,在它的催化下,可以直接从反应液中分离出D-缬氨酸,产率为60%。该方法的缺点是反应的前体DL-5-异丙基海因须用剧毒的氢氰酸制备,而且收率也不太高,距工业化生产还有一定距离。There are a large number of reports on microbial asymmetric conversion methods, representative of which are Italian scientists M.Battilotti and U.Barberini using enzymes produced by Agrobacterium radiata to catalyze the hydrolysis of DL-5-isopropylhydantoin. This bacteria is rich in hydantoin Under the catalysis of hydrolase and carbamoyl hydrolase, D-valine can be directly separated from the reaction liquid, and the yield is 60%. The disadvantage of this method is that the precursor of the reaction, DL-5-isopropylhydantoin, must be prepared with highly toxic hydrocyanic acid, and the yield is not too high, and there is still a certain distance from industrial production.
化学拆分法是一种古老而又年轻的方法。用化学拆分方法拆分、制备D-缬氨酸国外仅有少量报道。1934年D.F.Holmes用薄荷醇合成的手性试剂L-薄荷醇氧基乙酰氯与DL-缬氨酸生成非对映体酰胺,通过分级结晶将其分开,酰胺在乙醇水溶液中与HBr反应得光学活性D-缬氨酸。所用手性拆分剂合成需四步完成,整个拆分工艺过程比较繁琐,产品的光学纯度和收率也没有报导。1984年Tadashi Shiraiwa在含有L-苯丙氨酸和DL-缬氨酸的碱性溶液中用HCl调pH值至5.5,沉淀出L-苯丙氨酸和D-缬氨酸加合物,加合物溶于水后用活性炭吸附除去L-苯丙氨酸得到D-缬氨酸,其产率为49-63%,光学纯度为84-100%,产物的收率和光学纯度都不够高。Chemical resolution is an old and young method. There are only a few reports abroad on the separation and preparation of D-valine by chemical resolution methods. In 1934, D.F.Holmes used the chiral reagent L-mentholoxyacetyl chloride synthesized by menthol and DL-valine to generate diastereomeric amides, which were separated by fractional crystallization, and the amides reacted with HBr in aqueous ethanol to obtain optical Active D-Valine. The synthesis of the chiral resolving agent used needs to be completed in four steps, the whole resolution process is more loaded down with trivial details, and the optical purity and yield of the product are not reported. In 1984, Tadashi Shiraiwa used HCl to adjust the pH value to 5.5 in an alkaline solution containing L-phenylalanine and DL-valine, and precipitated L-phenylalanine and D-valine adducts. After the compound is dissolved in water, L-phenylalanine is removed by active carbon adsorption to obtain D-valine, and its productive rate is 49-63%, and the optical purity is 84-100%, and the yield and optical purity of the product are not high enough .
三、发明内容3. Contents of the invention
1、技术问题1. Technical issues
本发明的目的是提供一种制备D-缬氨酸和L-缬氨酸的化学拆分新方法,使用该方法拆分DL-缬氨酸所得产品收率高,光学纯度高。The purpose of the present invention is to provide a new chemical resolution method for preparing D-valine and L-valine, and the product obtained by using the method to resolve DL-valine has high yield and high optical purity.
2、技术方案2. Technical solution
本发明的化学拆分法制备左旋缬氨酸和右旋缬氨酸的方法,以外消旋缬氨酸(DL-Val)为原料,以无机酸为溶剂,以右旋二苯甲酰酒石酸(D-DBTA)和左旋二苯甲酰酒石酸(L-DBTA)为拆分剂,将外消旋-缬氨酸与拆分剂按物质量的比为1∶0.5-1.2的比例溶于稀的无机酸溶液中,在60-100℃下搅拌0.5-2.0小时,再逐渐冷却至室温,滤出结晶盐,结晶盐和母液分别在水、酒精溶剂中用碱中和,即分别得到左旋缬氨酸(D-Val)和右旋缬氨酸(L-Val),工艺路线为:The chemical resolution method of the present invention prepares the method for L-valine and D-valine, uses racemic valine (DL-Val) as raw material, takes mineral acid as solvent, and uses D-dibenzoyl tartaric acid (DL-Val) as a raw material. D-DBTA) and L-dibenzoyl tartaric acid (L-DBTA) are the resolving agent, and the racemic-valine and the resolving agent are dissolved in dilute dilute solution in the ratio of 1:0.5-1.2 In the inorganic acid solution, stir at 60-100°C for 0.5-2.0 hours, then gradually cool to room temperature, filter out the crystalline salt, and neutralize the crystalline salt and the mother liquor with alkali in water and alcohol solvent respectively to obtain L-valamine acid (D-Val) and D-valine (L-Val), the process route is:
其中H+为氢离子。Wherein H + is a hydrogen ion.
无机酸溶剂为稀盐酸或稀硫酸水溶液,溶剂的量为5~20倍于缬氨酸,酸的浓度为0.1~1.0mol/L。The inorganic acid solvent is dilute hydrochloric acid or dilute sulfuric acid aqueous solution, the amount of the solvent is 5 to 20 times that of valine, and the concentration of the acid is 0.1 to 1.0 mol/L.
氨化中和所需要的碱为氨气、氨水、三乙胺、碳酸铵、碳酸钠、碳酸钾、氢氧化钠。The alkali required for ammoniation neutralization is ammonia gas, ammonia water, triethylamine, ammonium carbonate, sodium carbonate, potassium carbonate, and sodium hydroxide.
氨化中和所用的溶剂为水和甲醇、乙醇、丙醇、异丙醇、正丁醇等低级脂肪醇及丙酮。The solvents used for ammoniation neutralization are water, methanol, ethanol, propanol, isopropanol, n-butanol and other lower aliphatic alcohols and acetone.
由于缬氨酸是只含有脂肪侧链的中性氨基酸,以酒石酸为原料合成了酸性较强的具有一定刚性的拆分剂D-DBTA和L-DBTA,它们分别和DL-Val形成非对映体盐,由于非对映体盐在酸性水溶液中的溶解度差别较大,故可成功将DL-Val拆分成D-Val和L-Val。Since valine is a neutral amino acid containing only aliphatic side chains, tartaric acid was used as a raw material to synthesize stronger acidic resolving agents D-DBTA and L-DBTA with certain rigidity, which formed diastereomers with DL-Val respectively. Diastereomeric salts, because diastereomeric salts have a large difference in solubility in acidic aqueous solution, so DL-Val can be successfully split into D-Val and L-Val.
用D-DBTA做拆分剂时,盐D-Val·D-DBTA在溶液中的溶解度较小,冷却后,从溶液中析出,其非对映体盐则留在溶液中。过滤得到的D-Val·D-DBTA用碱中和即可得到D-Val。拆分母液浓缩后用碱调pH值到5.5,即得L-Val。D-Val和L-Val的收率都在70%以上,光学纯度大于98%。When D-DBTA is used as a resolving agent, the salt D-Val·D-DBTA has a small solubility in the solution, and after cooling, it precipitates out of the solution, and its diastereomeric salt remains in the solution. The filtered D-Val·D-DBTA can be neutralized with alkali to obtain D-Val. After splitting and concentrating the mother liquor, adjust the pH value to 5.5 with alkali to obtain L-Val. The yields of both D-Val and L-Val are above 70%, and the optical purity is greater than 98%.
用L-DBTA做拆分剂有类似的情况,不同的是拆分时L-Val与L-DBTA形成的盐从溶液中沉淀析出,D-Val的盐则留在母液中。用碱处理相应的盐,也能得到目标产物,收率大于70%以上,光学纯度大于98%。A similar situation occurs when L-DBTA is used as a resolving agent. The difference is that the salt formed by L-Val and L-DBTA precipitates out of the solution during resolution, and the salt of D-Val remains in the mother liquor. The target product can also be obtained by treating the corresponding salt with alkali, with a yield of more than 70% and an optical purity of more than 98%.
外消旋缬氨酸与手性有机酸作用生成非对映体盐,非对映体盐在溶液中的溶解度不同,可借助溶解度的差异将它们分开。本发明中,当向DL-Val溶液中加入D-DBTA后,D-Val与D-DBTA所生成的盐在稀酸中溶解度较小,从溶液中析出,L-Val所生成的盐溶解度较大则留在溶液中。平衡一段时间后,通过过滤即可将它们分开。同样,当向DL-Val溶液中加入L-DBTA后,L-Val与L-DBTA所生成的盐在稀酸中溶解度较小,从溶液中析出,D-Val所生成的盐溶解度较大则留在溶液中。Racemic valine reacts with chiral organic acids to form diastereomeric salts. Diastereomeric salts have different solubility in solution, and they can be separated by virtue of the difference in solubility. In the present invention, after adding D-DBTA in the DL-Val solution, the salt generated by D-Val and D-DBTA has less solubility in dilute acid and will be separated out from the solution, and the salt generated by L-Val has lower solubility. Larger ones remain in solution. After equilibrating for a period of time, they can be separated by filtration. Similarly, when L-DBTA is added to the DL-Val solution, the salt generated by L-Val and L-DBTA has a lower solubility in dilute acid and precipitates out of the solution, while the salt generated by D-Val has a higher solubility. stay in solution.
由非对映体盐氨化制备D-Val或L-Val所依据的是简单的酸碱中和反应原理。The preparation of D-Val or L-Val by ammonification of diastereomeric salts is based on a simple acid-base neutralization reaction principle.
在本发明中,较强的碱氨水或三乙氨与较强的酸D-Val·D-DBTA作用生成较弱的酸酒石酸铵盐及较弱的碱D-Val。In the present invention, stronger base ammonia or triethylammonia reacts with stronger acid D-Val·D-DBTA to generate weaker acid ammonium tartrate and weaker base D-Val.
3、有益效果3. Beneficial effects
本发明所用拆分剂的合成原料易得、合成工艺简单;拆分后拆分剂可以回收再利用;拆分所用溶剂是稀酸水溶液,生产成本低,对环境污染小,无机酸副产The synthetic raw material of the resolving agent used in the present invention is easy to get, and the synthesis process is simple; The resolving agent can be recycled and reused after the resolving;
的铵盐可用于农业生产;无机酸的使用是该发明与传统的拆分工艺不同的特点,无机酸既有利于DL-Val的溶解,也减少拆分剂的用量。在最佳条件下,D-Val(左旋缬氨酸)拆分收率达到80%,光学纯度达到100%。The ammonium salt can be used in agricultural production; the use of inorganic acid is the characteristic that this invention is different from the traditional resolution process. The inorganic acid is not only beneficial to the dissolution of DL-Val, but also reduces the amount of resolution agent. Under optimal conditions, the resolution yield of D-Val (L-valine) reaches 80%, and the optical purity reaches 100%.
综上所述,本发明解决了由DL-Val制备D-Val和L-Val工艺中收率低、成本高等问题。因此,上述用DBTA作拆分剂由DL-Val制备D-Val和L-Val拆分工艺可用于工业化生产。In summary, the present invention solves the problems of low yield and high cost in the process of preparing D-Val and L-Val from DL-Val. Therefore, the above-mentioned resolution process for preparing D-Val and L-Val from DL-Val by using DBTA as a resolving agent can be used in industrial production.
四、具体实施方式4. Specific implementation
1、以DL-Val(外消旋—缬氨酸)为原料,以稀盐酸或稀硫酸为溶剂,通过化学拆分方法制备D-Val(左旋-缬氨酸)和L-Val(右旋-缬氨酸),1. Using DL-Val (racemic-valine) as raw material, using dilute hydrochloric acid or dilute sulfuric acid as solvent, prepare D-Val (L-Valine) and L-Val (D-Val) by chemical resolution -valine),
2、拆分剂为二苯甲酰酒石酸D-DBTA和L-DBTA。2. The resolving agent is dibenzoyl tartaric acid D-DBTA and L-DBTA.
3、拆分溶剂为稀盐酸、稀硫酸或其它稀的无机强酸水溶液。溶剂的量为5-20倍于缬氨酸,最适用量为缬氨酸的8-16倍。酸的浓度0.1-1.0mol/L,最适浓度为0.2-0.8mol/L。3. The resolution solvent is dilute hydrochloric acid, dilute sulfuric acid or other dilute inorganic strong acid aqueous solution. The amount of solvent is 5-20 times of valine, and the most suitable amount is 8-16 times of valine. The acid concentration is 0.1-1.0mol/L, and the optimum concentration is 0.2-0.8mol/L.
4、拆分反应的温度为70-100℃,最适宜温度为75-95℃。4. The temperature of the resolution reaction is 70-100°C, and the optimum temperature is 75-95°C.
5、非对映体盐洗涤所用溶剂为乙醚、丙酮、乙醇、水等。5. The solvents used for diastereomeric salt washing are ether, acetone, ethanol, water, etc.
6、氨化中和所需要的碱为氨气、氨水、三乙胺、碳酸铵、碳酸钠、碳酸钾、氢氧化钠等。6. The alkali required for ammoniation neutralization is ammonia gas, ammonia water, triethylamine, ammonium carbonate, sodium carbonate, potassium carbonate, sodium hydroxide, etc.
7、氨化中和所用的溶剂为水和甲醇、乙醇、丙醇、异丙醇、正丁醇等低级脂肪醇及丙酮。7. The solvents used for ammoniation neutralization are water, methanol, ethanol, propanol, isopropanol, n-butanol and other lower aliphatic alcohols and acetone.
工艺路线:Routing:
实施例1:Example 1:
2.34g DL-Val溶于20ml稀盐酸中,在搅拌下加热至80-100℃,加入3.58gL-DBTA,在该温度下反应半小时,然后在60℃保持1小时,逐渐有沉淀生成,再冷却至15℃左右,抽滤,滤饼溶于30ml乙醇及2倍量的三乙胺中,搅拌1小时,抽滤,并用乙醇洗涤,干燥得0.94g L-Val,拆分收率80.3%,[α]D22=+27.5°。拆分母液浓缩后用碱调节调pH值为5.5,搅拌,有白色固体析出,抽滤并用乙醇洗涤,干燥得0.84gD-Val,收率71.8%,[α]D22=-27.5°。Dissolve 2.34g of DL-Val in 20ml of dilute hydrochloric acid, heat to 80-100°C under stirring, add 3.58g of L-DBTA, react at this temperature for half an hour, then keep at 60°C for 1 hour, gradually a precipitate forms, and then Cool to about 15°C, filter with suction, dissolve the filter cake in 30ml of ethanol and 2 times the amount of triethylamine, stir for 1 hour, filter with suction, wash with ethanol, dry to obtain 0.94g of L-Val, and the resolution yield is 80.3% , [α]D 22 =+27.5°. After splitting and concentrating the mother liquor, adjust the pH value to 5.5 with alkali, stir, a white solid precipitates out, filter with suction, wash with ethanol, and dry to obtain 0.84 g of D-Val with a yield of 71.8%, [α]D 22 =-27.5°.
实施例2:Example 2:
2.34g DL-Val溶于20ml稀盐酸中,搅拌,加热至90-100℃,加入3.76gD-DBTA,在该温度下反应50分钟,然后60℃保持1小时,逐渐有沉淀生成,再冷却至15℃左右,抽滤并用水洗涤,滤饼溶于30ml乙醇及2倍量的三乙胺中,搅拌1小时,抽滤,并用乙醇洗涤,干燥得0.94g D-Val,拆分收率80.3%,[α]D22=-30°。拆分母液浓缩后用碱调节pH值为5.5,搅拌,有白色固体析出,抽滤并用乙醇洗涤,干燥得0.83g L-Val,收率70.9%,[α]D22=+27.5°。Dissolve 2.34g of DL-Val in 20ml of dilute hydrochloric acid, stir, heat to 90-100°C, add 3.76g of D-DBTA, react at this temperature for 50 minutes, then keep at 60°C for 1 hour, gradually a precipitate forms, and then cool to At about 15°C, filter with suction and wash with water, dissolve the filter cake in 30ml of ethanol and 2 times the amount of triethylamine, stir for 1 hour, filter with suction, wash with ethanol, dry to obtain 0.94g of D-Val, and the resolution yield is 80.3 %, [α]D 22 = -30°. After splitting and concentrating the mother liquor, adjust the pH value to 5.5 with alkali, stir, a white solid precipitates out, filter with suction, wash with ethanol, and dry to obtain 0.83g of L-Val, yield 70.9%, [α]D 22 =+27.5°.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031321372A CN1186313C (en) | 2003-07-01 | 2003-07-01 | Methof for preparing l-valine and d-valine by using chemical resolution process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031321372A CN1186313C (en) | 2003-07-01 | 2003-07-01 | Methof for preparing l-valine and d-valine by using chemical resolution process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1477096A CN1477096A (en) | 2004-02-25 |
CN1186313C true CN1186313C (en) | 2005-01-26 |
Family
ID=34153999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031321372A Expired - Fee Related CN1186313C (en) | 2003-07-01 | 2003-07-01 | Methof for preparing l-valine and d-valine by using chemical resolution process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1186313C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100352801C (en) * | 2004-11-17 | 2007-12-05 | 王旭 | Synthesis method of L-n-valaine |
CN102070473B (en) * | 2009-11-20 | 2013-10-16 | 上海雅本化学有限公司 | Method for synthesizing D-valine |
US9120722B1 (en) | 2014-08-14 | 2015-09-01 | Wellman Biosciences Co. Ltd. | Optically active valine complex and a method for producing the same |
CN115181032B (en) * | 2022-07-28 | 2023-08-22 | 天津大学 | A method for the resolution of DL-valine racemic compounds based on selective co-crystallization/salt formation |
-
2003
- 2003-07-01 CN CNB031321372A patent/CN1186313C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1477096A (en) | 2004-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2460799C2 (en) | Method of producing crystals of basic amino acid hydrochloride | |
CN101659622A (en) | Method for splitting valine | |
IE892227L (en) | New process for the synthesis of the levodopa | |
CN1186313C (en) | Methof for preparing l-valine and d-valine by using chemical resolution process | |
KR100399509B1 (en) | Process for purifying valine | |
CN103333180B (en) | Preparation method of aspoxicillin | |
US9120722B1 (en) | Optically active valine complex and a method for producing the same | |
JP5112658B2 (en) | Method for producing α-hydroxycarboxylic acid | |
CN1876628A (en) | Method for preparing levocysteine and dextral cysteine using chemical resolution method | |
CN111072547A (en) | Chemical preparation method of 2-azabicyclo [2.2.1] hept-5-ene-3-ketone with optical activity | |
CN104557677A (en) | Chemical resolution preparation method for optical pure 2-pipecolic acid | |
CN1876631A (en) | Method for preparing D-tryptophan using asymmetric conversion method | |
CN1226275C (en) | Method for preparing D-phenylalanine by asymmetric conversion method | |
CN1900298A (en) | Method for preparing D-tyrosine by enzyme method | |
CN112940031B (en) | N-naphthyl-acetyl-glufosinate-ammonium, synthesis method thereof and synthesis method for synthesizing L-glufosinate-ammonium by using N-naphthyl-acetyl-glufosinate-ammonium | |
EP2502896B1 (en) | A process for the preparation of enantiomerically pure tert-leucine | |
JPH052665B2 (en) | ||
JP2971291B2 (en) | Production method of optically active 2-aminobutyric acid | |
CN1274656C (en) | New technique for preparing alpha halogenate acid in class of optical purity | |
CN1252035C (en) | Novel chiral amino acid derivative and its synthetic method and use | |
CN104592046A (en) | Optically active valine compound and production method thereof | |
CN100391934C (en) | Method for preparing L-glutamic acid | |
CN108623598A (en) | A kind of preparation method of Imipenem intermediate and Imipenem | |
CN100334222C (en) | Enzyme method for preparing laevo-rotation and dextro-rotation tryptophane 15N by resolving racemic tryptophase 15N | |
JP2505487B2 (en) | Racemization of optically active lysine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |